Glutathione: Discovery and Research History

Introduction

The history of glutathione (GSH; γ-L-glutamyl-L-cysteinyl-glycine) spans more than a century of biochemical investigation. From the earliest descriptions of a mysterious reducing substance in biological extracts to the elucidation of its precise molecular structure, enzymatic functions, and redox signaling roles, the scientific development of glutathione reflects the broader maturation of biochemistry as a discipline. This article provides an educational reference account of the major milestones in that history, based on published primary literature and historical reviews. Sourcing and batch-verification standards for research-grade glutathione are covered separately in the glutathione sourcing and quality article.

Discovery Period: 1888–1929

The first documented description of a substance with glutathione-like properties predates Frederick Hopkins' canonical 1921 isolation. In 1888, the French chemist J. de Rey-Pailhade reported a water-soluble compound isolated from yeast with the property of reducing elemental sulfur to hydrogen sulfide. He named this compound "philothion" — from the Greek, meaning "love of sulfur" — recognizing thiol-based chemistry without being able to characterize the molecule's identity [1].

The field remained without a structural framework for this substance until Frederick Gowland Hopkins, working in the Biochemistry Department at Cambridge, isolated a thiol-containing compound from yeast and animal muscle tissues in 1921 and named it "glutathione," reflecting its content of glutamic acid and cysteine. Hopkins reported that the compound was autooxidizable — readily converting between reduced and oxidized forms — and possessed the reducing properties noted by de Rey-Pailhade. The initial characterization positioned glutathione as a dipeptide of glutamate and cysteine [1].

The structural debate advanced through the late 1920s. In 1929, Hopkins revised his structural interpretation, establishing that glutathione was a tripeptide containing glutamic acid, cysteine, and glycine. That same year, Hopkins received the Nobel Prize in Physiology or Medicine — an award recognizing his body of work on nutritional biochemistry and accessory food factors, with glutathione research as a prominent component of his scientific legacy [1].

Structural Elucidation and Early Chemistry: 1929–1950

The confirmation of glutathione's full chemical structure required additional years of synthetic chemistry work. Charles Robert Harington and Thomas Mead reported the chemical synthesis of glutathione and confirmed its structure as γ-L-glutamyl-L-cysteinyl-glycine in 1935, resolving earlier ambiguity about the peptide linkage geometry [1]. The key insight was the recognition of the γ-peptide linkage — the bond between the γ-carboxyl group of glutamate's side chain and the α-amine of cysteine — as distinct from the standard α-peptide bonds found in conventional proteins. This unusual linkage, as later research established, confers resistance to degradation by conventional cellular proteases and underpins the molecule's extended intracellular stability.

Early biochemical studies in the 1930s and 1940s established GSH's oxidation-reduction properties and provided initial evidence for its high concentrations in many tissues. Albert Szent-Györgyi's laboratory reported in 1931 that cabbage leaf tissue reduced oxidized ascorbic acid through a process involving glutathione oxidation, connecting GSH to the chemistry of another important biological reducing agent. The development of reliable quantitative methods for measuring tissue glutathione content in the 1940s enabled systematic characterization of GSH distribution across tissues and animal species, establishing that the compound was a universal biological feature rather than an organism-specific curiosity.

Early Enzymatic Research: 1950s–1970s

The characterization of glutathione's enzymatic functions represented the central advance of the mid-20th century. Investigators in the 1950s and 1960s identified and characterized the glutathione S-transferases as a distinct enzyme class catalyzing the conjugation of GSH to electrophilic substrates. Early work by Booth, Boyland, and Sims described the formation of mercapturic acids in animal tissues as products of glutathione conjugation to aromatic compounds — establishing that the GST pathway served a function in xenobiotic metabolism and putting GSH at the center of drug detoxification biology [2].

The characterization of glutathione peroxidase (GPx) by Gordon Mills in 1957 introduced a major additional dimension to glutathione biochemistry. Mills reported that erythrocytes contained an enzyme that catalyzed the reduction of hydrogen peroxide using GSH as the electron donor. Subsequent investigation over the following two decades characterized GPx as a selenoenzyme, established the mechanism of the selenium-containing active site, and identified multiple GPx isoforms with distinct tissue distributions and substrate preferences — each representing a distinct line of research that continues today [3].

The γ-glutamyl cycle — a conceptual framework proposing that glutathione participates in membrane-associated amino acid transport through sequential extracellular degradation and intracellular resynthesis — was proposed by Alton Meister and colleagues in the early 1970s based on the properties of γ-glutamyl transpeptidase (GGT) and the GSH biosynthetic enzymes [4]. Meister's subsequent decades of research at Cornell University Medical College constituted one of the most concentrated single-laboratory contributions to glutathione biochemistry, encompassing the characterization of glutamate-cysteine ligase (GCL), the development of specific enzyme inhibitors, and broad surveys of GSH metabolism.

Molecular Biology Era: 1980s–2000s

The molecular cloning of genes encoding GSH biosynthetic enzymes and GSH-dependent antioxidant enzymes in the 1980s and 1990s opened new avenues of investigation. Cloning of the catalytic (GCLC) and modifier (GCLM) subunits of glutamate-cysteine ligase enabled characterization of the enzyme's transcriptional regulation and provided tools for generating genetically modified animal models.

Mouse models with targeted disruption of GCLM were viable but showed substantially reduced GSH concentrations in several tissues and increased sensitivity to oxidative insults in experimental models. These genetic findings contributed to characterizing GSH as an essential endogenous biomolecule and provided a powerful platform for probing the molecule's biological roles in vivo.

The identification of nuclear factor erythroid 2-related factor 2 (Nrf2) and its repressor Keap1 as a stress-responsive transcriptional system governing GCL subunit expression in the 1990s and early 2000s connected glutathione biology to a broader network of antioxidant gene regulation. Research from the laboratory of Masayuki Yamamoto and others established that Nrf2 binds antioxidant response elements (AREs) in the promoters of GCLC, GCLM, and numerous other genes encoding antioxidant proteins, providing a transcriptional basis for the adaptive upregulation of GSH biosynthesis under oxidative conditions [5].

Current Research Landscape

Contemporary research on glutathione spans several productive and interconnected directions. The characterization of S-glutathionylation as a post-translational redox signaling mechanism has generated substantial interest since the 2000s, with proteomics-based studies identifying hundreds of candidate S-glutathionylated proteins in various cell types and conditions. The glutaredoxin enzymes — which catalyze both the formation and removal of S-glutathionylation modifications — have been the subject of detailed mechanistic and structural investigations [2].

The role of GPx4 in ferroptosis — a form of regulated cell death involving accumulation of lipid peroxides — emerged as a major research focus in the 2010s following the characterization of ferroptosis as a distinct cell death modality. Research reported that GPx4, which uses GSH to reduce membrane-embedded lipid hydroperoxides, constitutes a central regulator of ferroptosis susceptibility, positioning the glutathione system within a form of regulated cell death attracting substantial interest in cancer biology [3].

Clinical investigation of glutathione supplementation has grown in volume across the 2010s and 2020s. Studies examining liposomal and other modified-delivery oral GSH formulations have reported that these approaches may result in greater measurable changes in blood GSH parameters than standard oral preparations, with ongoing trials investigating the durability and significance of those changes. The intersection of GSH biology with aging research — in which declining GSH levels have been reported in aged tissues in multiple animal and human studies — has attracted sustained interest as a focus for interventional investigations [4]. A similar aging-focused research trajectory has developed around NAD+, another endogenous metabolite in the mitochondrial and metabolic research cluster that shares the theme of age-associated decline in biosynthetic capacity.

The development of genetically encoded fluorescent glutathione sensors has provided new experimental tools for investigating compartment-specific GSH dynamics in real time within living cells, a methodological advance that continues to clarify the spatial complexity of the glutathione redox network that earlier biochemical methods could not resolve.

References

1. Meister A. On the discovery of glutathione. Trends Biochem Sci. 1988;13(5):185-188. PMID: 3076280. DOI: 10.1016/0968-0004(88)90148-X

2. Aquilano K, Baldelli S, Ciriolo MR. Glutathione: new roles in redox signaling for an old antioxidant. Front Pharmacol. 2014;5:196. PMID: 25206336. DOI: 10.3389/fphar.2014.00196

3. Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020;152:175-185. PMID: 31981735. DOI: 10.1016/j.freeradbiomed.2020.01.027

4. Meister A, Anderson ME. Glutathione. Annu Rev Biochem. 1983;52:711-760. PMID: 6137189. DOI: 10.1146/annurev.bi.52.070183.003431

5. Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009;30(1-2):1-12. PMID: 18796312. DOI: 10.1016/j.mam.2008.08.006